1. Home
  2. BPMC vs CHA Comparison

BPMC vs CHA Comparison

Compare BPMC & CHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • CHA
  • Stock Information
  • Founded
  • BPMC 2008
  • CHA 2017
  • Country
  • BPMC United States
  • CHA China
  • Employees
  • BPMC N/A
  • CHA N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • CHA
  • Sector
  • BPMC Health Care
  • CHA
  • Exchange
  • BPMC Nasdaq
  • CHA NYSE
  • Market Cap
  • BPMC 5.8B
  • CHA 5.5B
  • IPO Year
  • BPMC 2015
  • CHA 2025
  • Fundamental
  • Price
  • BPMC $101.35
  • CHA $28.01
  • Analyst Decision
  • BPMC Buy
  • CHA
  • Analyst Count
  • BPMC 18
  • CHA 0
  • Target Price
  • BPMC $125.88
  • CHA N/A
  • AVG Volume (30 Days)
  • BPMC 789.4K
  • CHA 1.1M
  • Earning Date
  • BPMC 05-01-2025
  • CHA 05-30-2025
  • Dividend Yield
  • BPMC N/A
  • CHA N/A
  • EPS Growth
  • BPMC N/A
  • CHA 186.29
  • EPS
  • BPMC N/A
  • CHA 1.95
  • Revenue
  • BPMC $562,121,000.00
  • CHA $1,699,604,333.00
  • Revenue This Year
  • BPMC $44.49
  • CHA N/A
  • Revenue Next Year
  • BPMC $33.04
  • CHA N/A
  • P/E Ratio
  • BPMC N/A
  • CHA $14.34
  • Revenue Growth
  • BPMC 99.19
  • CHA 167.35
  • 52 Week Low
  • BPMC $73.04
  • CHA $27.21
  • 52 Week High
  • BPMC $121.90
  • CHA $41.80
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 56.34
  • CHA N/A
  • Support Level
  • BPMC $94.38
  • CHA N/A
  • Resistance Level
  • BPMC $102.52
  • CHA N/A
  • Average True Range (ATR)
  • BPMC 3.77
  • CHA 0.00
  • MACD
  • BPMC -0.38
  • CHA 0.00
  • Stochastic Oscillator
  • BPMC 79.29
  • CHA 0.00

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About CHA CHAGEE HOLDINGS LTD SPON ADS EACH R SPON ADS EACH REP 1 CL A

Chagee Holdings Ltd is a premium tea drinks brand. It is engaged in the sales of freshly-made tea drinks, related raw materials, packaging, teahouse equipment and other supplies in China.

Share on Social Networks: